MONTREAL, Sept. 8, 2011 /CNW Telbec/ - Noveko International Inc. (TSX:
EKO) (the "Company") is pleased to announce that its subsidiary SARL
Noveko Algérie ("Noveko Algérie"), following a selection by way of a
call for tenders by Algeria's National Office of Equipment and
Accessories for Handicapped People ("the NOEAHP"), has won firm orders
for the supply of medical devices (technical walking aids) worth a
total of 1.25 million Canadian dollars at current prices. Deliveries of
this equipment are scheduled to extend until December 31, 2011.
"We are very pleased to further build upon a partnership based on
expertise and know-how sharing with the NOEAHP. Won following a
rigorous selection process and fitting in with a business development
framework, these new orders attest to the quality of our products and
after-sales service as well as the renewed confidence of the NOEAHP.
They also represent an additional example of the great potential of
this market," indicated Mr. Mourad Ramdane, President and General
Manager of Noveko Algérie.
The NOEAHP is a statutory body reporting to the Algerian Ministry of Labour and
Social Security whose public mission is to meet the needs of people
with disabilities and reduced mobility in order to favour their
re-education, rehabilitation and social reintegration. To that end, the
NOEAHP is responsible for the manufacture, distribution and maintenance
of orthopedic devices, other technical walking aids, hearing aids as
well as other medical equipment and accessories.
Noveko International Inc. offers innovative solutions in the environmental and medical fields
worldwide. Through its subsidiaries, the Company specializes primarily
in the following business segments: the development, manufacturing and
marketing of derivative products from its patented antimicrobial
filtration technologies, mainly air filters, surgical masks and
respirators, as well as other products with antibacterial properties
such as hand sanitizers - and the development, manufacturing and
marketing of medical equipment, including portable real-time ultrasound
scanners for use in human and veterinary medicine.
Certain statements set forth in this press release constitute
forward-looking statements. In some cases, these statements are
identified by the use of terms such as "may", "could", "might",
"intend", "should", "expect", "project", "plan", "believe", "estimate"
or other comparable variants. These statements are based on the
information available at the time they are written, on assumptions made
by management and on the expectations of management, acting in good
faith, regarding future events, including those relating to economic
conditions, fluctuations in exchange rates and operating expenses, and
the absence of unusual events entailing supplementary expenditures.
Although management considers these assumptions and expectations
reasonable based on the information available at the time they are
written, they could prove inaccurate. Forward-looking statements are
also subject, by their very nature, to known and unknown risks and
uncertainties such as those related to the industry, acquisitions,
labor relations, credit, key officers, supply and product liability.
The actual results of Noveko International Inc. could differ materially
from those indicated or underlying these forward-looking statements.
The reader is therefore recommended not to unduly rely on these
forward-looking statements. Forward-looking statements do not reflect
the potential impact of special items, any business combination or any
other transaction that may be announced or occur subsequent to the date
hereof. Unless otherwise required under securities laws, the Company
does not intend and undertakes no obligation to update or revise the
forward-looking statements to reflect new information, new events or
SOURCE NOVEKO INTERNATIONAL INC.
For further information:
Chantal Vennat, Director,
Investor Relations and Corporate Communications
Noveko International Inc.
Tel: (514) 875-0606